hongbo wang
Yantai University
Yantai, China
Review Editor
Cancer Molecular Targets and Therapeutics
Yantai University
Yantai, China
Review Editor
Cancer Molecular Targets and Therapeutics
Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, China
Review Editor
Cancer Molecular Targets and Therapeutics
School of Basic Medical Sciences, Nanchang university
Nanchang, China
Review Editor
Cancer Molecular Targets and Therapeutics
Henry Ford Health System
Detroit, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Shanghai East Hospital, School of Medicine, Tongji University
Shanghai, China
Review Editor
Cancer Molecular Targets and Therapeutics
National Institutes of Health (NIH)
Bethesda, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Houston Methodist Research Institute
Houston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine
Guangzhou, China
Review Editor
Cancer Molecular Targets and Therapeutics
Seoul National University
Seoul, Republic of Korea
Review Editor
Cancer Molecular Targets and Therapeutics
Department of Immunotherapy, Henan Provincial Cancer Hospital
Zhengzhou, China
Review Editor
Cancer Molecular Targets and Therapeutics
Manipal Institute of Regenerative Medicine
Bangalore, India
Review Editor
Cancer Molecular Targets and Therapeutics
University of Maryland Eastern Shore
Princess Anne, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Xuzhou Medical University
Xuzhou, China
Review Editor
Cancer Molecular Targets and Therapeutics
Colorado State University
Fort Collins, United States
Review Editor
Cancer Molecular Targets and Therapeutics
University of Liverpool
Liverpool, United Kingdom
Review Editor
Cancer Molecular Targets and Therapeutics
Chang Gung University
Taoyuan, Taiwan
Review Editor
Cancer Molecular Targets and Therapeutics